Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: Preliminary observations

Journal of Experimental and Clinical Cancer Research

Volumn 27, Issue 1, 2008, Pages

  Spugnini, Enrico P ^a   Crispi, Stefania ^b   Scarabello, Alessandra ^c   Caruso, Giovanni ^d   Citro, Gennaro ^a   Baldi, Alfonso ^d  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b Human Molecular Genetics Laboratory   (Italy)

^c SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PIROXICAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER REGRESSION; CANCER SURGERY; CYTOREDUCTIVE SURGERY; DRAIN; DRUG EFFICACY; DRUG WITHDRAWAL; ECHOGRAPHY; EXPERIMENTAL CAT; EXPERIMENTAL DOG; HEMATOCHEZIA; MALIGNANT MESOTHELIOMA; MESOTHELIUM; METASTASIS; MULTIPLE CYCLE TREATMENT; NONHUMAN; OBSERVATIONAL STUDY; PET ANIMAL; PRIORITY JOURNAL; TREATMENT DURATION; TUMOR BIOPSY; ANIMAL; ANIMAL DISEASE; CAT; CAT DISEASE; DOG; DOG DISEASE; DRUG ADMINISTRATION; DRUG ADMINISTRATION ROUTE; MESOTHELIOMA; PLEURA TUMOR;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARBOPLATIN; CAT DISEASES; CATS; DOG DISEASES; DOGS; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; MESOTHELIOMA; PIROXICAM; PLEURAL NEOPLASMS;

EID: 44949101294     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-27-6     Document Type: Article

References (34)

1. Malignant mesothelioma. BWS Robinson AW Musk RA Lake, The Lancet 2005 366 397 408 10.1016/S0140-6736(05)67025-0
2. The European mesothelioma epidemic. J Peto A Decarli C La Vecchia F Levi E Negri, Br J Cancer 1999 79 666 672 10.1038/sj.bjc.6690105 10027347
3. Mechanisms in the pathogenesis of asbestosis and silicosis. BT Mossman A Chung, Am J Respir Crit Care Med 1998 157 1666 80 9603153
4. Human malignant mesothelioma: Molecular mechanisms of pathogenesis and progression. EP Spugnini S Bosari G Citro F Cognetti A Baldi, Int J Biochem Cell Biol 2006 38 2000 2004 10.1016/j.biocel.2006.07.002 16963313
5. Cell cycle molecules in mesothelioma: an overview. EP Spugnini M Campioni A D'Avino G Caruso G Citro A Baldi, J Exp Clin Cancer Res 2007 26 443 449 18365537
6. SV40 detection in human tumor specimens. M Carbone MA Rdzanek JJ Rudzinski MA De Marco M Bocchetta M Ramos Nino B Mossman HI Pass, Cancer Res 2005 65 10120 10121 10.1158/0008-5472.CAN-05-1911 16267039
7. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. A De Luca A Baldi V Esposito CM Howard L Bagella P Rizzo M Caputi HI Pass GG Giordano F Baldi M Carbone A Giordano, Nat Med 1997 3 913 916 10.1038/nm0897-913 9256285
8. Evidence against a role for SV40 in human mesothelioma. JJ Manfredi J Dong WJ Liu L Resnick-Silverman R Qiao P Chahinian M Saric AR Gibbs JI Phillips J Murray CW Axten RP Nolan SA Aaronson, Cancer Res 2005 65 2602 2609 10.1158/0008-5472.CAN-04-2461 15805256
9. Chemotherapy for malignant pleural mesothelioma. S Tomek C Manegold, Curr Opin Oncol 2003 15 148 56 10.1097/00001622-200303000-00006 12601280
10. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. D Curran T Sahmoud P Therasse J Van meerbeeck PE Postmus G Giaccone, J Clin Oncol 1998 16 145 52 9440736
11. Randomized phase II trial of CDDP with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B. AP Chahinian K Antman M Goutsou JM Corson Y Suzuki C Modeas JE Herndon 2nd J Aisner RR Ellison L Leone, J Clin Oncol 1993 11 1559 65 8336195
12. Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. MK Samson LP Wasser EC Borden HJ Wanebo RH Creech M Phillips LH Baker, J Clin Oncol 1987 5 86 91 3543239
13. Randomised phase II study of CDDP-etoposide versus infusional carboplatin in advanced non small-cell lung cancer and mesothelioma. SC White H Anderson GC Jayson L Ashcroft M Ranson N Thatcher, Ann Oncol 2000 11 201 206 10.1023/A:1008328605413 10761756
14. Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma. A Hughes P Calvert A Azzabi R Plummer R Johnson J Rusthoven M Griffin K Fishwick AV Boddy M Verrill H Calvert, J Clin Oncol 2002 20 3422 44 10.1200/JCO.2002.10.073
15. Gemcitabine for malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B. HL Kindler F Millard JE Herndon 2nd NJ Vogelzang Y Suzuki MR Green, Lung Cancer 2001 31 311 317 10.1016/S0169-5002(00)00166-5 11165412
16. Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma. EP Spugnini I Cardillo A Verdina S Crispi S Saviozzi R Calogero A Nebbioso L Altucci G Cortese R Galati J Chien V Shridhar B Vincenzi G Citro F Cognetti A Sacchi A Baldi, Clin Cancer Res 2006 12 6133 6143 10.1158/1078-0432.CCR-06-1056 17062690
17. Tumours of serosal surfaces. KW Head RW Else RR Dubielzig, Tumors of domestic Animals Iowa State Press, Ames, Meuten DJ, 4 2002 365 399
18. Abdominal mesothelioma in a cat. CP Raflo SP Nuernberger, Vet Pathol 1978 15 781 783 751315
19. A case of feline peritoneal mesothelioma with psammoma bodies. Jpn. K Akiyama Y Suzuki, J Vet Sci 1982 44 975 979
20. Ten cases of feline mesothelioma: an immunohistochemical and ultrastructural study. B Bacci F Morandi M De Meo PS Marcato, J Comp Pathol 2006 134 347 354 10.1016/j.jcpa.2006.02.001 16712862
21. Malignant mesothelioma with metastases and mast cell leukaemia in a cat. Y Kobayashi H Usuda K Ochiai C Itakura, J Comp Pathol 1994 111 453 458 10.1016/S0021-9975(05)80103-3 7884062
22. Pleural mesothelioma in a young cat. M Rinke M Rosenbruch, Dtsch Tierarztl Wochenschr 2003 110 4 177 178 12756962
23. Lymphatic metastasis in a case of feline peritoneal mesothelioma. Y Suzuki M Sugimura Y Atoji K Akiyama, Jpn J Vet Sci 1985 47 511 516
24. Palliative intracavitary carboplatin therapy in a cat with suspected pleural mesothelioma. A Sparkes S Murphy F McConnell K Smith AS Blunden K Papasouliotis D Vanthournout, J Feline Med Surg 2005 7 5 313 316 10.1016/j.jfms.2005.03.006 15914055
25. Intracavitary cisplatin chemotherapy experience with six dogs. AS Moore C Kirk A Cardona, J Vet Intern Med 1991 5 227 31 1658318
26. Donald Plumb Ed, Plumb's Veterinary Drug Handbook Ames, Blackwell Publishing 5 2005
27. Pericardiectomy in dogs: 22 cases (1986-1996). KK Kerstetter DJ Krahwinkel DL Millis K Hahn, J Am Vet Med Assoc 1997 211 736 740 9301745
28. Thoracoscopic partial pericardiectomy in 13 dogs. J Jackson K Richter D Launer, J Vet Intern Med 1999 13 529 533 10.1892/0891-6640(1999)013<0529: TPPID>2.3.CO;2 10587251
29. Efficacy of mitoxantrone against various neoplasms in dogs. GK Ogilvie JE Obradovich RE Elmslie DM Vail AS Moore RC Straw K Dickinson MF Cooper SJ Withrow, J Am Vet Med Assoc 1991 198 1618 1621 2061177
30. Phase II evaluation of doxorubicin for treatment of various canine neoplasms. GK Ogilvie HA Reynolds RC Richardson SJ Withrow AM Norris RA Henderson JS Klausner JD Fowler D McCaw, J Am Vet Med Assoc 1989 195 1580 1583 2599941
31. Idiopathic or mesothelioma-related pericardial effusion: clinical findings and survival in 17 dogs (1983-1996). RL Stepien NW Whitley RR Dubielzig, J Small Anim Pract 2000 41 342 347 10.1111/j.1748-5827.2000.tb03215.x 11002935
32. Effects of tetracycline hydrochloride on pleurae in dogs with induced pleural effusion. LA Gallagher SJ Birchard SE Weisbrode, Am J Vet Res 1990 51 1682 1687 2240791
33. Use of pleurodesis in treating selected pleural diseases. SJ Birchard L Gallagher, Compend Contin Educ Pract Vet 1988 10 826 832
34. Oncology of companion animals as a model for humans. an overview of tumor histotypes. A Porrello P Cardelli EP Spugnini, J Exp Clin Cancer Res 2006 25 97 105 16761625